A Study of JNJ-64304500 in Participants With Alopecia Areata

NCT04740970 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Sponsor Decision.

Conditions

Alopecia Areata

Interventions

DRUG: JNJ-64304500
DRUG: Placebo

Sponsor

Janssen Research & Development, LLC